BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 495304)

  • 21. Application of bradykinin radioimmunoassay for the measurement of urinary kallikrein activity rats.
    Stocker M; Hornung J
    Klin Wochenschr; 1978; 56 Suppl 1():127-9. PubMed ID: 732246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary kininogen: a possible regulator of kinin formation in normal individuals and subjects with essential hypertension, end-stage renal and liver disease.
    Weinberg MS; Trebbin WM; Solomon RJ
    Adv Exp Med Biol; 1986; 198 Pt A():119-25. PubMed ID: 3812087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on human kininogens. I. Isolation, characterization, and cleavage by plasma kallikrein of high molecular weight (HMW)-kininogen.
    Nakayasu T; Nagasawa S
    J Biochem; 1979 Jan; 85(1):249-58. PubMed ID: 104988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Purification of human low molecular weight kininogen, and its application for the sensitive method of human urinary kallikrein activity].
    Kondo M; Shimamoto K; Ura N; Mita A; Nishimiya T
    Horumon To Rinsho; 1984 Jan; 32(1):91-7. PubMed ID: 6561979
    [No Abstract]   [Full Text] [Related]  

  • 25. Isolation and properties of two rat plasma T-kininogens.
    Okamoto H; Greenbaum LM
    Adv Exp Med Biol; 1986; 198 Pt A():69-75. PubMed ID: 3544720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Urinary kallikrein quantity and activity in normal pregnant women in the third trimester].
    Hiruta M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1156-60. PubMed ID: 3849561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new fluorogenic substrate method for the estimation of kallikrein in urine.
    Kato H; Adachi N; Iwanaga S; Abe K; Takada K; Kimura T; Sakakibara S
    J Biochem; 1980 Apr; 87(4):1127-32. PubMed ID: 6901529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kallikrein-kinin system in severe experimental hypertension.
    Quadra JA; Bossolan D; Stella RC; Ribeiro AB; Kohlmann O; Ramos OL
    Adv Exp Med Biol; 1986; 198 Pt B():313-9. PubMed ID: 3643729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of human high molecular weight kininogen digestion by plasma kallikrein and by plasmin. A revised method of purification of high molecular weight kininogen.
    Kleniewski J; Donaldson VH
    J Lab Clin Med; 1987 Apr; 109(4):469-79. PubMed ID: 2950194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens.
    Maier M; Austen KF; Spragg J
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):3928-32. PubMed ID: 6575386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological abnormality of kallikrein-kinin system in hypertension.
    Sharma JN; Fernandez PG
    Med Hypotheses; 1982 Oct; 9(4):379-84. PubMed ID: 6925142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue distribution and kininogen gene expression after acute-phase inflammation.
    Chao J; Swain C; Chao S; Xiong W; Chao L
    Biochim Biophys Acta; 1988 Mar; 964(3):329-39. PubMed ID: 3126819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active-site labeling of rat and human urinary kallikrein by chloro(N alpha-p-tosyllysyl)methane.
    Chao J
    Hoppe Seylers Z Physiol Chem; 1981 Aug; 362(8):1113-8. PubMed ID: 6921142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Similarity between a kininogenase (kallikrein) from human large intestine and human urinary kallikrein.
    Zimmermann A; Geiger R; Kortmann H
    Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1767-73. PubMed ID: 260927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individual reaction steps in the release of kallidin from kininogen by tissue kallikrein.
    Fiedler F; Hinz H; Lottspeich F
    Adv Exp Med Biol; 1986; 198 Pt A():283-9. PubMed ID: 3643712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the kinin formation by bovine spleen acid kininogenases.
    Yamafuji K; Watanabe M
    Adv Exp Med Biol; 1983; 156():409-18. PubMed ID: 6552847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity of the amidase and kininogenase methods for the determination of rat urinary kallikrein.
    Berthoud VM; Corthorn JL
    J Clin Chem Clin Biochem; 1987 Sep; 25(9):595-600. PubMed ID: 3681198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase in renal and urinary low and high molecular weight kininogens during chromate-induced acute renal failure in the rat: evidence for renal kininogen production.
    Bompart G; Collé A; Dos Reiss ML; Pécher C; Adam A; Girolami JP
    Nephron; 1993; 65(4):612-8. PubMed ID: 8302419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
    Vinci JM; Gill JR; Bowden RE; Pisano JJ; Izzo JL; Radfar N; Taylor AA; Zusman RM; Bartter FC; Keiser HR
    J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrolysis of human high-molecular-mass kininogen by human plasma kallikrein. Proposal of a new model concept for the course of reaction in presence and absence of C1(-)-inhibitor.
    Wiedler J; Dutler H
    Biol Chem Hoppe Seyler; 1987 Sep; 368(9):1203-13. PubMed ID: 3675872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.